Featuring the ERC’s decision to split from Plan S, a report on the Open Pharma June 2020 virtual roundtable meeting in BMJ Opinion, solutions for improving transparency, the Data Ethics Canvas tool, Beck et al.’s recommendations for preprint server best practice, a concerning increase in citation rates for journals discontinued from the Scopus database and … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the new cOAlition S Rights Retention Strategy, an analysis of institutional open access output, subjectivity in peer review reports, insights on opening up science to the public, appeals against Clarivate’s blacklist decision and concerns of questionable editorial practices. The new Rights Retention Strategy via cOAlition S To ensure the compliance of exclusive publishing agreements … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the grey area surrounding predatory journals, a breakdown of APC price increases, The Company of Biologists’ decision to freeze fees, the Metadata 2020 Principles, how researchers feel about data sharing technologies and the University of Cambridge’s response to UKRI Open Access Review consultation. Defining predatory journals via The Publication Plan The line between predatory … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the evolving landscape of scientific publishing in the wake of COVID-19, the new journal dedicated to COVID-19 research, best practice for social media communication in the medical community, the Department for Business, Energy & Industrial Strategy’s R&D roadmap, a ‘How To’ guide for patient engagement and case studies in open science. Change is coming … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the FDA’s Project Patient Voice, certification for ORCID service providers, a call for responsible reporting of COVID-19 mathematical models, an analysis of open peer review journals, how the ABPI will navigate Brexit and the changing landscape of research communication. Introducing Project Patient Voice via Bloomberg Law Project Patient Voice is a pilot initiative from … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring debriefs from the June 2020 Open Pharma roundtable meeting and the virtual 16th Annual Meeting of ISMPP, questions and answers on patient authorship, a joint letter urging publishers to reduce fee agreements with UK universities, a landmark deal from the University of California and the results of the COAR open access repository platform survey. … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the questionable transparency of some COVID-19 data, retraction notices and clinical trial results, what COVID-19 has taught us about open access, a centralized archive of COVID-19 preprints, and how the pandemic may affect the public’s trust in science. Data transparency amid COVID-19 journal retractions via the BMJ The lessons learned from the British Medical … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring changes in publishing practices, a preprint on missing safety data, a copyright infringement lawsuit, promoting Principle 5 of Plan S and price transparency, PubMed’s new preprint platform, and how to define and identify predatory journals. Recipes for perpetuity via The Scholarly Kitchen This month’s installation of The Scholarly Kitchen’s Ask the Chefs column asks: … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring new endorsements of the Open Pharma position statement on open access, preprints, preprints, preprints, and updates on open access agreements from the University of California and swissuniversities. New organizational endorsements and 150 individual endorsements via Open Pharma Open Pharma is pleased to announce that we have now gained 150 individual endorsements on our position … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring an abstract from ISMPP’s 16th Annual Meeting, Springer Nature’s commitment to DORA, a reflection on how COVID-19 is impacting clinical research, interpretations of the meaning of open science, preprint policy updates from PLOS, a public appeal to the EMA and what’s standing in the way of open access. Coco et al. 2020: surveying open … Continue reading Weekly digest: what’s happening in open science?